Pvolve's Strength Training Boosts Health and Balance in All Ages
Pvolve, a leading functional fitness brand, has demonstrated significant benefits of its strength training program for overall health and healthy aging. A recent study at the University of Exeter revealed substantial improvements in lower body strength, flexibility, and balance among participants.
Pvolve's method, designed for long-term adherence, involves progressive overload and functional movements. This approach helps maintain muscle composition and improves joint health. The study found that participants, including those pre-, peri-, and post-menopause, experienced nearly 20% increase in lower body strength, over 20% improvement in flexibility, and up to 13% better balance after just 12 weeks.
Pvolve is now evolving its programming to meet the growing need for muscle preservation among users of GLP-1 medications, which can lead to muscle loss. Dr. Nima Alamdari, Pvolve's Chief Scientific and Clinical Advisor, supports the importance of strength training for healthy aging and longevity. Pvolve's future focus is on training for lifestyle support and long-term functionality, rather than short-term results or aesthetics. By building confidence in one's ability to maintain independence and resilience, Pvolve's programming aims to promote healthy living at all ages.
The study at the University of Exeter underscores the benefits of Pvolve's strength training program for overall health and healthy aging. With its 'joint-smart' and progressive approach, Pvolve is committed to helping users maintain and build muscle mass, a crucial ingredient for healthy living at all ages. As GLP-1 medication users face muscle loss, Pvolve's evolving programming offers a vital solution for muscle preservation and long-term functionality.
Read also:
- Intestinal Infection Causing Stomach Distress: Signs and Remedies
- What is the expected timing for the flu season in this current year?
- Essential Information on Cushing Syndrome: a Disorder Caused by High Cortisol Levels
- Starting in September, elderly individuals aged 75 years and above will be enrolled in a preventive program for Respiratory Syncytial Virus (RSV).
